Current approaches in CRISPR-Cas9 mediated gene editing for biomedical and therapeutic applications-Reference-Cited by-同舟云学术

Current approaches in CRISPR-Cas9 mediated gene editing for biomedical and therapeutic applications

Published:2022-03 Issue: Volume:343 Page:703-723
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Bhattacharjee Gargi,Gohil Nisarg,Khambhati Khushal,Mani Indra,Maurya Rupesh,Karapurkar Janardhan Keshav,Gohil Jigresh,Chu Dinh-Toi,Vu-Thi Hue,Alzahrani Khalid J.,Show Pau-Loke,Rawal Rakesh M.,Ramakrishna Suresh,Singh Vijai

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference236 articles.

1. Pathophysiology of sickle cell disease;Sundd;Annu. Rev. Pathol.,2019

2. Beta-thalassemia;Galanello;Orphanet J. Rare Dis.,2010

3. Hemophilia A and B: molecular and clinical similarities and differences;Castaman;Haematologica,2019

4. Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA;Long;Science,2014

5. Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs;Firth;Cell Rep.,2015

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biotechnology Advances in Disease Treatment;International Encyclopedia of Public Health;2025

2. Carrying both the heterozygous Myh6-R453C and Tnnt2-R92W mutations aggravate the hypertrophic cardiomyopathy phenotype in mice;Biochemical and Biophysical Research Communications;2024-11

3. Convergence of CRISPR and artificial intelligence: A paradigm shift in biotechnology;Human Gene;2024-09

4. CRISPR-CAS9-MEDIATED EX VIVO GENE EDITING FOR INHERITED HEMATOLOGICAL DISORDERS: ADVANCEMENTS, CHALLENGES, AND CLINICAL POTENTIAL;International Journal of Pharmacy and Pharmaceutical Sciences;2024-09-01

5. A paper-based assay for detecting hypervirulent Klebsiella pnuemoniae using CRISPR-Cas13a system;Microchemical Journal;2024-08